Table 4.
Distribution of clinical actions among all actionable device-detected events (19 in the Control group and 37 in the Remote group) followed by a clinical decision.
| Actionable device-detected event | Patient education | Device programming | Medication changes | Hospitalizations | Laboratory tests | ||||||
| Cont. group | Rem. group | Cont. group | Rem. group | Cont. group | Rem. group | Cont. group | Rem. group | Cont. group | Rem. group | ||
| AT/AF burden: at least 6 hrs of AT/AF in a single day (Control group n=5, Remote group n=14) |
6 | 4 | 2 | 2 | 4 | 8 | 2 | 0 | 0 | 1 | |
| Fast V rate during AT/AF: Mean V rate of at least 100 bpm a day with at least 6 hrs of AT/AF (Control group n=0, Remote group n=2) |
0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | |
| # of shocks delivered in an episode (at least 2) (Control group n=1, Remote group n=2) |
0 | 0 | 0 | 2 | 0 | 1 | 1 | 0 | 0 | 0 | |
| OptiVol threshold crossing for lung fluid accumulation (Control group n=11, Remote group n=19) |
1 | 6 | 3 | 4 | 9 | 13 | 2 | 0 | 0 | 0 | |
| Lead impedances out of range (Control group n=2, Remote group n=0) |
0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | |